| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.534 | 6.318 | 6.573 | 5.989 | 3.617 | 5.958 | 7.448 | 6.997 | 7.249 | 2.267 |
| Total Income - EUR | 6.624 | 6.318 | 6.573 | 5.989 | 3.617 | 6.218 | 8.971 | 8.903 | 9.800 | 2.766 |
| Total Expenses - EUR | 6.591 | 5.741 | 3.908 | 3.259 | 5.566 | 8.356 | 4.187 | 5.239 | 4.483 | 3.631 |
| Gross Profit/Loss - EUR | 34 | 578 | 2.665 | 2.730 | -1.949 | -2.139 | 4.785 | 3.663 | 5.317 | -865 |
| Net Profit/Loss - EUR | -165 | 388 | 2.468 | 2.550 | -2.057 | -2.313 | 4.521 | 3.402 | 4.581 | -865 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Paracelsus Med Chim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.659 | 3.245 | 3.066 | 3.010 | 2.952 | 2.896 | 2.832 | 2.840 | 2.832 | 2.816 |
| Current Assets | 3.088 | 2.239 | 2.838 | 3.859 | 2.081 | 1.545 | 4.336 | 7.699 | 11.985 | 10.499 |
| Inventories | 1.682 | 1.291 | 1.538 | 1.198 | 1.140 | 48 | 47 | 47 | 47 | 47 |
| Receivables | 1.382 | 729 | 677 | 666 | 835 | -1 | 3.745 | 6.934 | 11.505 | 9.522 |
| Cash | 24 | 218 | 623 | 1.994 | 106 | 1.498 | 543 | 717 | 433 | 931 |
| Shareholders Funds | 914 | 1.293 | 3.738 | 6.220 | 4.042 | 1.652 | 6.136 | 9.557 | 14.110 | 13.165 |
| Social Capital | 5.203 | 5.150 | 5.062 | 4.970 | 4.873 | 4.781 | 4.675 | 4.689 | 4.675 | 4.649 |
| Debts | 5.834 | 4.191 | 2.166 | 649 | 991 | 2.789 | 1.031 | 982 | 707 | 150 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2012 - 2012" | |||||||||
| CAEN Financial Year |
2012
|
|||||||||
Comments - Paracelsus Med Chim S.r.l.